Predict your next investment

Venture Capital
FINANCE | Investment Firms & Funds
emvcapital.com

See what CB Insights has to offer

Investments

16

Portfolio Exits

1

About EMV Capital

EMV Capital is a London-based early-stage venture investor focused on B2B companies in the industrial high-tech, energy, circular economy, smart cities and transportation sectors and healthcare.On August 24th, 2020, EMV Capital was acquired by NetScientific. Terms of the transaction were not disclosed.

EMV Capital Headquarter Location

Level 39, One Canada Square

London, England, E14 5AB,

United Kingdom

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest EMV Capital News

NetScientific acquiring 30% stake in 'materially de-risked' Vortex Biotech

May 6, 2022

The board sees "substantial upside potential" through a multi-pronged growth strategy Vortex specialises in the capture and analysis of circulating tumour cells found in the bloodstream of cancer sufferers NetScientific PLC (AIM:NSCI) said it is acquiring a 30% stake in former investee company Vortex Biotech in a non-cash transaction. It has conditionally agreed to buy the stake in Vortex Biotech Holdings, an Anglo-American technology group that specialises in circulating tumour cell capture and analysis, which provides doctors and scientists with insights into the prevalence and development of cancers as well as guiding potential treatments. Under previous management, NetScientific completed a forced sale of a 95% holding in the business in 2019. Since being spun out of the University of California, Los Angeles (UCLA), Vortex has benefited from US$$38.5mln of historic investment and NetScientific believes the business has been "materially de-risked" in the period since previous management exited. It has made "significant commercial and operational progress, underpinning significant growth prospects", investors were told. With Vortex active in the fast-growing oncology research and liquid biopsy markets, similar to AIM-listed ANGLE, the NetScientific board sees "substantial upside potential" through a growth strategy focused on product and cartridge sales, launching a services lab business, and exploring liquid biopsy opportunities. “The board is accordingly delighted for the group to be in a position to re-acquire an interest in Vortex,” NetScientific added. The consideration for the acquisition is to be satisfied by the transfer of £300,000 of invoices to extinguish obligations and fees payable by Vortex US to EMV Capital for previous services and certain loans made to Vortex by Deeptech. Deeptech was managed by EMV Capital, which has since been bought by NetScientific.

EMV Capital Investments

16 Investments

EMV Capital has made 16 investments. Their latest investment was in Bureau as part of their Series A on December 12, 2021.

CBI Logo

EMV Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

12/16/2021

Series A

Bureau

$12M

Yes

15

12/13/2021

Unattributed VC - II

Martlet Capital

No

1

11/16/2021

Seed VC - II

Clinikk

$4M

Yes

10

9/16/2021

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

6/22/2021

Seed VC - II

Subscribe to see more

$99M

Subscribe to see more

10

Date

12/16/2021

12/13/2021

11/16/2021

9/16/2021

6/22/2021

Round

Series A

Unattributed VC - II

Seed VC - II

Unattributed VC

Seed VC - II

Company

Bureau

Martlet Capital

Clinikk

Subscribe to see more

Subscribe to see more

Amount

$12M

$4M

$99M

$99M

New?

Yes

No

Yes

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

15

1

10

10

10

EMV Capital Portfolio Exits

1 Portfolio Exit

EMV Capital has 1 portfolio exit. Their latest portfolio exit was Credenc on August 20, 2021.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

8/20/2021

Acquired

2

Date

8/20/2021

Exit

Acquired

Companies

Valuation

Acquirer

Sources

2

EMV Capital Acquisitions

2 Acquisitions

EMV Capital acquired 2 companies. Their latest acquisition was Vortex Biosciences on April 26, 2019.

Date

Investment Stage

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Total Funding

Note

Sources

4/26/2019

Other

$99M

$0.37M

Acq - Fin

2

4/17/2019

Subscribe to see more

$99M

Subscribe to see more

10

Date

4/26/2019

4/17/2019

Investment Stage

Other

Companies

Subscribe to see more

Valuation

$99M

$99M

Total Funding

$0.37M

Note

Acq - Fin

Subscribe to see more

Sources

2

10

EMV Capital Team

2 Team Members

EMV Capital has 2 team members, including current Managing Director, Ilian Iliev.

Name

Work History

Title

Status

Ilian Iliev

EcoMachines Incubator

Managing Director

Current

Dr. Iliev

Managing Director

Current

Name

Ilian Iliev

Dr. Iliev

Work History

EcoMachines Incubator

Title

Managing Director

Managing Director

Status

Current

Current

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.